Aeras Community Engagement Program

Aeras’s Community Engagement (CE) program is integral to the clinical trials we conduct with our partners.  CE programs establish relationships between researchers and stakeholders within communities where clinical trials take place, creating a platform for the local community to partner with the scientific community in research efforts. We are committed to continuing this important collaboration with clinical trial sites, activists, PDPs, communities and other stakeholders to ensure appropriate community engagement is integrated into the development of new safe and affordable TB vaccines.

Good Participatory Practice Guidelines

Aeras is committed to following Good Participatory Practice (GPP) Guidelines, which stress the importance of building transparent, sustained, trusting and mutually beneficial partnerships with all stakeholders, with the goal of working together to shape vaccine research and development. Aeras supports the principles outlined in the guidelines, including respect, mutual understanding, integrity, transparency, accountability and community stakeholder autonomy. In this effort, stakeholders may include those within the local community, as well as regional, national and global levels, and may take on different roles and responsibilities in the design, conduct, analysis and results dissemination of a TB vaccine trial.

Strategic Priorities for Community Engagement

  1. Implement GPP at all clinical trial sites involved in TB vaccine clinical trials.
  2. Establish a TB Vaccine Community Engagement Network that is utilized as a trusted resource for stakeholders involved in GPP implementation for TB vaccine clinical trials.
  3. Collaborate with organizations involved in community or stakeholder engagement related to TB or TB vaccine clinical trials to leverage potential efficiencies and resources across organizations.

Email us with comments or questions about Aeras’s Community Engagement Program or our resources.